// App-Quantinova.ai

1078 : Glucocorticoid Use and Related Adverse Events in ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis

Researchers

Presenter

  • Emil De Gomma

Principal Investigators

  • Peter Merkel

  • Michael George

  • Rennie Rhee

  • Andreas Kronbichler

  • David Jayne

  • Huibin Yue

  • Pirow Bekker

Medical Centers

  • ChemoCentryx, San Juan Capistrano, CA

  • University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania, Philadelphia, PA

  • Cambridge University, Sale Creek, TN

  • University of Cambridge, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Glucocorticoid

  • Oraprine

  • Prednisone

  • Rituximab

  • CCX-168

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved